Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers in Women with Obesity and Other Risk Factors for Breast Cancer
Study Type: Prevention
Phase: Feasibility/Pilot
NCTID: NCT06485089
Principal Investigator:
Carol Fabian
Advancing Tobacco Use Treatment for African American Smokers
Study Type: Prevention
Phase: IV
NCTID: NCT02360631
Principal Investigator:
Lisa Cox
ARM: AXILLARY REVERSE MAPPING ? A PROSPECTIVE TRIAL TO STUDY RATES OF LYMPHEDEMA AND REGIONAL RECURRENCE AFTER SENTINEL LYMPH NODE BIOPSY AND SENTINEL LYMPH NODE BIOPSY FOLLOWED BY AXILLARY LYMPH NODE DISSECTION WITH AND WITHOUT AXILLARY REVERSE MAPPING
Randomized IIB Study of the Effect of Bazedoxifene plus Conjugated Estrogens on Breast Imaging and Tissue Biomarkers in Peri or Post-Menopausal Women at Increased Risk for Development of Breast Cancer
StepByStep: A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention among Adolescent and Young Adult Childhood Cancer Survivors
Study Type: Prevention
Phase: III
NCTID: NCT04089358
Principal Investigator:
Keith August
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Cessation Interventions
Phase 1b Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Repeated Doses of DB-020 in Patients Receiving Cisplatin
FORTE Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body Radiotherapy SABRE
Study Type: Prevention
Phase: N/A
NCTID: NCT04905069
Principal Investigator:
Ronald Chen
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine DFMO
Study Type: Prevention
Phase: II
NCTID: NCT02679144
Principal Investigator:
Kevin Ginn